The term 'opioid' is a generic term for naturally occurring, semisynth
etic and synthetic drugs which combine with opioid receptors to produc
e physiological effects and which are stereospecifically antagonised b
y naloxone. For clinical purposes, opioids can be classified according
to their receptor interactions (agonist, partial agonist, agonist-ant
agonist and antagonist), the pain intensity for which they are convent
ionally used (moderate or severe), and their half-life (short or long)
. Pure agonists conventionally used for moderate pain, short and long
half-life pure agonists conventionally used for severe pain, mixed ago
nist-antagonists and partial agonist opioids are described in detail.
The effective clinical use of opioid drugs requires familiarity with d
rug selection, routes of administration, dosage guidelines and potenti
al adverse effects. Opioids are unequivocally indicated in the managem
ent of severe acute pain and moderate to severe pain associated with c
ancer. There is increasing acceptance of the role of opioids in the ma
nagement of recurring acute pain, chronic nonmalignant pain of organic
origin and severe neuropathic pain. The selection of opioids is influ
enced by pain intensity, pharmacokinetic and formulary considerations,
previous adverse effects and the presence of coexisting disease. Some
patients will require sequential trials of several different opioids
before a drug which is effective and well tolerated is identified. Opi
oid agents should be administered by the most comfortable and convenie
nt route that meets the specific needs of the patient. The regimen for
opioid medications should generally provide around-the-clock analgesi
a with provision for rescue doses for the management of exacerbations
of the pain not covered by the regular dosage. At all times, uncontrol
led pain should be addressed by gradual increase in the opioid dose un
til either pain control is achieved or intolerable and unmanageable ad
verse effects supervene. The management of pain with opioid analgesics
demands frequent patient assessment and a readiness to re-evaluate th
e therapeutic plan in the setting of either inadequate relief or adver
se effects.